臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"tseng t c"

Return to Browse by Author
Sorting by Title	Sort by Date

Showing items 336-360 of 534 (22 Page(s) Totally)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2021-05-24T07:20:46Z	Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load	Tseng T.-C.; Liu C.-J.; Yang H.-C.; Su T.-H.; Wang C.-C.; Chen C.-L.; Fang-Tzu Kuo S.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:46Z	High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load	Tseng T.-C.; Liu C.-J.; Yang H.-C.; Su T.-H.; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:46Z	Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin	CHEN-HUA LIU; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:46Z	Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy	CHEN-HUA LIU; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:45Z	Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B	Pan C.J.-H.; Wu H.-L.; Kuo S.F.-T.; Kao J.-H.; Tseng T.-C.; CHEN-HUA LIU; Chen P.-J.; Liu C.-J.; Chen D.-S.
臺大學術典藏	2021-05-24T07:20:45Z	Impact of hepatitis B virus infection on metabolic profiles and modifying factors	Hsu C.-S.; CHEN-HUA LIU; Wang C.-C.; Tseng T.-C.; Liu C.-J.; Chen C.-L.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:44Z	Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin	Yu M.-L.; CHEN-HUA LIU; Huang C.-F.; Tseng T.-C.; Huang J.-F.; Dai C.-Y.; Lin Z.-Y.; Chen S.-C.; Wang L.-Y.; Juo S.-H.H.; Chuang W.-L.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:44Z	Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivation	Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:43Z	Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads	Tseng T.-C.; Liu C.-J.; Yang H.-C.; Su T.-H.; Wang C.-C.; Chen C.-L.; Hsu C.-A.; Fang-Tzu Kuo S.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:43Z	Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion	Yang H.-C.; Chen C.-L.; Shen Y.-C.; Peng C.-Y.; Liu C.-J.; Tseng T.-C.; Su T.-H.; Chuang W.-L.; Yu M.-L.; Dai C.-Y.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:42Z	Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype	Huang C.-F.; Yu M.-L.; Kao J.-H.; Tseng T.-C.; Yeh M.-L.; Huang J.-F.; Dai C.-Y.; Lin Z.-Y.; Chen S.-C.; Wang L.-Y.; Juo S.H.H.; Chuang W.-L.; CHEN-HUA LIU
臺大學術典藏	2021-05-24T07:20:42Z	Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection	Su T.-H.; Liu C.-J.; Tseng T.-C.; CHEN-HUA LIU; Yang H.-C.; Chen C.-L.; Chen P.-J.; Kao J.-H.; Chen D.-S.
臺大學術典藏	2021-05-24T07:20:41Z	Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers	Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Yang W.-T.; Kuo S.F.-T.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:41Z	Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C	Su T.-H.; CHEN-HUA LIU; Liu C.-J.; Chen C.-L.; Ting T.-T.; Tseng T.-C.; Chen P.-J.; Kao J.-H.; Chen D.-S.
臺大學術典藏	2021-05-24T07:20:40Z	Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters	Tseng T.-C.; Liu C.-J.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:39Z	Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously	Cheng H.-R.; Kao J.-H.; Wu H.-L.; Chen T.-C.; Tseng T.-C.; CHEN-HUA LIU; Su T.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J.
臺大學術典藏	2021-05-24T07:20:39Z	Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy	Su T.-H.; Liu C.-J.; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; CHEN-HUA LIU; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:37Z	Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: Comparison of genotypes B and C at various immune stages	Liu C.-J.; Chen T.-C.; Chen P.-J.; Wang H.-Y.; Tseng T.-C.; Cheng H.-R.; CHEN-HUA LIU; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:37Z	Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection	Cheng H.-R.; Kao J.-H.; Wu H.-L.; Tseng T.-C.; CHEN-HUA LIU; Yang H.-C.; Su T.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J.
臺大學術典藏	2021-05-24T07:20:36Z	Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection	Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang W.-T.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:36Z	Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients	Wang C.-C.; CHEN-HUA LIU; Lin C.-L.; Wang P.-C.; Tseng T.-C.; Lin H.H.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:35Z	Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition	Su T.-H.; Shiau C.-W.; Jao P.; CHEN-HUA LIU; Liu C.-J.; Tai W.-T.; Jeng Y.-M.; Yang H.-C.; Tseng T.-C.; Huang H.-P.; Cheng H.-R.; Chen P.-J.; Chen K.-F.; Kao J.-H.; Chen D.-S.
臺大學術典藏	2021-05-24T07:20:34Z	Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers	Tseng T.-C.; Liu C.-J.; Yang H.-C.; Chen C.-L.; Yang W.-T.; Tsai C.-S.; Kuo S.F.-T.; Verbree F.C.; Su T.-H.; Wang C.-C.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:32Z	Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study	Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; CHEN-HUA LIU; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:31Z	Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C	Mah Y.-H.; CHEN-HUA LIU; Chen C.-L.; Tseng T.-C.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H.

Showing items 336-360 of 534 (22 Page(s) Totally)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| Total items :2832440
	Visitors : 33824634 Online Users : 1290 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library